SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-087083
Filing Date
2023-08-03
Accepted
2023-08-03 09:04:24
Documents
12
Period of Report
2023-08-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2317748d1_8k.htm   iXBRL 8-K 30712
  Complete submission text file 0001104659-23-087083.txt   206273

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA repl-20230803.xsd EX-101.SCH 3018
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE repl-20230803_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE repl-20230803_pre.xml EX-101.PRE 22361
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2317748d1_8k_htm.xml XML 3412
Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

IRS No.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38596 | Film No.: 231138311
SIC: 2836 Biological Products, (No Diagnostic Substances)